Evaluation of the performances of the new Synchron (R) C-RP reagent in the determination of the atherosclerotic risk in apparently healthy patients.

Wawrzyniak, J; De Nayer, Philippe; Philippe, Marianne

doi:10.1373/49.1.113

Evaluation of the performances of the new Synchron (R) C-RP reagent in the determination of the atherosclerotic risk in apparently healthy patients.

Wawrzyniak, J

;

De Nayer, Philippe

;

Philippe, Marianne

(2003) 55th Annual Meeting of the American-Association-for-Clinical-Chemiatry — Location: PHILADELPHIA (Pennsylvania) (20.July.2003)

Files

No attached file found for this publication.

Details

Authors

Wawrzyniak, J
Author
De Nayer, PhilippeUCLouvain
Author
Philippe, Marianne
Author

Affiliations

UCLouvainMD/BICL - Département de biochimie et de biologie cellulaire

Citations

APA
Chicago
FWB

Wawrzyniak, J., De Nayer, P., & Philippe, M. (2003). Evaluation of the performances of the new Synchron (R) C-RP reagent in the determination of the atherosclerotic risk in apparently healthy patients. Clinical Chemistry : international journal of molecular diagnostics and laboratory medicine, 49(6), A113-A114. https://doi.org/10.1373/49.1.113 (Original work published 2003)